课题基金 / 基金详情

STRUCTURE/FUNCTION OF THE INTEGRIN ALPHA 1 BETA 1

STRUCTURE/FUNCTION OF THE INTEGRIN ALPHA 1 BETA 1
整合素 ALPHA 1 BETA 1 的结构/功能
批准号:
6519402
负责人:
EUGENE E. MARCANTONIO
金额:
$36.97万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 2003-06-30

项目摘要

项目成果

EUGENE E. MARCANTONIO的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自申请人摘要):本更新提案的主要目标是确定整合素a1b1的细胞内信号的机制和后果。配体结合后,该受体产生多种信号,组织肌动蛋白细胞骨架和刺激细胞生长。先前的研究已经表明,交换a1和β 1的胞质结构域导致整合素具有缺陷的信号传导,尽管它具有结合配体的能力。β亚基的胞质结构域内的插入可以恢复该受体的信号传导特性。该模型将用于研究信号转导后跨膜构象变化的机制。第二个目标将比较野生型和缺陷型受体,以剖析通过FAK的信号传导的近端方面。在缺陷受体中,FAK被激活,但嵌合受体不磷酸化CAS。研究将集中在cSrc及其介导FAK和CAS之间信号传导的能力。将表达cSrc的突变形式以确定它们是否将拯救缺陷受体。第三个目标将集中在通过适配器Shc的a1b1生长信号。在Jurkat细胞中的研究发现,与成纤维细胞相反,在这些细胞中需要受体酪氨酸磷酸酶CD 45和Src激酶Lck,并且Src激酶Fyn是不足的。研究将解决Src激活和Shc信号传导的机制。最后,研究将使用两种胶原蛋白受体a1b1和a2b1来解决上述生长信号的后果,这两种胶原蛋白受体在磷酸化Shc的能力上不同。该系统将用于检查与肽生长因子受体信号协同作用中所涉及的整合素信号的性质。
英文摘要
DESCRIPTION (Adpated from applicant's abstract): The primary goal of this renewal proposal is to determine the mechanism and consequences of intracellular signals from the integrin a1b1. Upon ligand binding, this receptor produces multiple signals which organize the actin cytoskeleton and stimulant cell growth. Previous studies have shown that swapping the cytoplasmic domains of a1 and beta1 leads to an integrin with defective signaling despite its capacity to bind ligand. An insertion within the cytoplasmic domain of the beta subunit can restore the signaling properties of this receptor. This model will be used to study the mechanism of the transmembrane conformation change occurring upon signaling. The second aim will compare wild type and defective receptors to dissect the proximal aspects of signaling via FAK. In the defective receptor FAK is activated yet the chimeric receptor does not phosphorylate CAS. Studies will focus upon cSrc and its ability to mediate the signaling between FAK and CAS. Mutant forms of cSrc will be expressed to determine if they will rescue the defective receptors. The third aim will focus on a1b1 growth signals through the adaptor Shc. Studies in Jurkat cells found that the receptor tyrosine phosphatase CD45 and the Src kinase Lck are required and the Src kinase Fyn is not sufficient in the these cells, in contrast to fibroblasts. Studies will address the mechanism of Src activation and Shc signaling. Finally, studies will address the consequences of the above mentioned growth signals using the two collagen receptors a1b1 and a2b1, which differ in their ability to phosphorylate Shc. This system will be use to examine the nature of integrin signals involved in the synergy with peptide growth factor receptor signals.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
The role of the I domain in ligand binding of the human integrin alpha 1 beta 1.
I 结构域在人整合素 α 1 β 1 配体结合中的作用。
DOI: --
发表时间: 1994
期刊: The Journal of biological chemistry
影响因子: --
作者: [Kern,A, Briesewitz,R, Bank,I, Marcantonio,EE]
通讯作者: Marcantonio,EE
Integrin-mediated tyrosine phosphorylation of Shc in T cells is regulated by protein kinase C-dependent phosphorylations of Lck.
T 细胞中整合素介导的 Shc 酪氨酸磷酸化受到蛋白激酶 C 依赖性 Lck 磷酸化的调节。
DOI: 10.1091/mbc.e02-07-0382
发表时间: 2003
期刊: Molecular biology of the cell
影响因子: 3.3
作者: [Niu,Shi, Xie,Haichun, Marcantonio,EugeneE]
通讯作者: Marcantonio,EugeneE
Expression of native and truncated forms of the human integrin alpha 1 subunit.
人类整合素 α 1 亚基的天然形式和截短形式的表达。
DOI: --
发表时间: 1993
期刊: The Journal of biological chemistry
影响因子: --
作者: [Briesewitz,R, Epstein,MR, Marcantonio,EE]
通讯作者: Marcantonio,EE
Integrin beta 1 cytoplasmic domain dominant negative effects revealed by lysophosphatidic acid treatment.
溶血磷脂酸治疗揭示了整合素β1细胞质结构域显性负面影响。
DOI: 10.1091/mbc.5.11.1215
发表时间: 1994
期刊: Molecular biology of the cell
影响因子: 3.3
作者: [Smilenov,L, Briesewitz,R, Marcantonio,EE]
通讯作者: Marcantonio,EE
Ph 2a Study of S48168 (ARM210) for CPVT 1 IND 152773 (09/11/2020)
  • 批准号:
    10280877
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2021
  • 负责人:
    EUGENE E. MARCANTONIO
  • 依托单位:
Ph 2a Study of S48168 (ARM210) for CPVT 1 IND 152773 (09/11/2020)
  • 批准号:
    10492470
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2021
  • 负责人:
    EUGENE E. MARCANTONIO
  • 依托单位:
INTEGRINS AND T CELL DEVELOPMENT AND FUNCTION
INTEGRINS AND T CELL DEVELOPMENT AND FUNCTION
海外基金